Aclaris Therapeutics, Inc. (LON:0H8T)
1.135
-0.014 (-1.25%)
At close: Apr 16, 2025
Aclaris Therapeutics Employees
As of December 31, 2024, Aclaris Therapeutics had 64 total employees, including 61 full-time and 3 part-time employees. The number of employees decreased by 27 or -29.67% compared to the previous year.
Employees
64
Change (1Y)
-27
Growth (1Y)
-29.67%
Revenue / Employee
237.35K GBP
Profits / Employee
-1.67M GBP
Market Cap
96.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,315 |
Aclaris Therapeutics News
- 7 weeks ago - Aclaris Therapeutics to Participate in Two March Healthcare Conferences - GlobeNewsWire
- 7 weeks ago - Aclaris Therapeutics plans $300M mixed shelf offering - Seeking Alpha
- 2 months ago - New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3 - GlobeNewsWire
- 2 months ago - Aclaris Therapeutics: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule - Seeking Alpha
- 2 months ago - Aclaris Therapeutics Announces Formation of New Scientific Advisory Board - GlobeNewsWire
- 3 months ago - Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy - Benzinga
- 4 months ago - Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy - Benzinga